Structural basis for inhibition of the MDM2:p53 interaction by an optimized MDM2-binding peptide selected with mRNA display.
The oncoprotein MDM2 binds to tumor suppressor protein p53 and inhibits its anticancer activity, which leads to promotion of tumor cell growth and tumor survival. Abrogation of the p53:MDM2 interaction reportedly results in reactivation of the p53 pathway and inhibition of tumor cell proliferation....
Main Authors: | Takashi Nagata, Kie Shirakawa, Naohiro Kobayashi, Hirokazu Shiheido, Noriko Tabata, Yuko Sakuma-Yonemura, Kenichi Horisawa, Masato Katahira, Nobuhide Doi, Hiroshi Yanagawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4183577?pdf=render |
Similar Items
-
mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction.
by: Hirokazu Shiheido, et al.
Published: (2011-03-01) -
MIP-2A is a novel target of an anilinoquinazoline derivative for inhibition of tumour cell proliferation.
by: Mayuko Tokunaga, et al.
Published: (2013-01-01) -
Regulation of the tumor suppressor p53 by Mdm2 and Mdm4
by: Maetens, Marion
Published: (2007) -
Regulation of the tumor suppressor p53 by Mdm2 and Mdm4
by: Maetens, Marion M.
Published: (2007) -
Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
by: Zuzana Mrkvová, et al.
Published: (2019-06-01)